Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanya Chandra

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Opinion on Emerging Drugs|June 30, 2020
Clinical trials and novel therapeutics in dermatomyositisTanya Chandra, Rohit Aggarwal
Rheumatology and Therapy|March 26, 2023
A Narrative Review of Acthar Gel for the Treatment of MyositisTanya Chandra, Rohit Aggarwal
Cureus|November 9, 2019
Adalimumab-induced Anti-neutrophilic Cytoplasmic Antibody Vasculitis: A Rare Complication of an Increasingly Common TreatmentTanya Chandra, Joy-Ann Tabanor-Gayle, Santhanam Lakshminarayanan
Indian Journal of Pediatrics|December 22, 2016
Complexities in Genotype-Phenotype Correlation and Genetic Counseling in Collagen VI - Related MyopathyMalavika Hebbar, Tanya Chandra, Anju Shukla, et al.
Rheumatology (Oxford, England)|February 6, 2024
Patient-reported outcome for physical function in idiopathic inflammatory myopathyShiri Keret, Raisa Lomanto Silva, Tanya Chandra, et al.
Clinical Rheumatology|August 26, 2024
Internet-based enrollment of a myositis patient cohort-a national experienceRaisa Lomanto Silva, Shiri Keret, Tanya Chandra, et al.
Clinical and Experimental Rheumatology|February 25, 2026
Fitbit as an activity monitor in idiopathic inflammatory myopathy: results from a real-world cohortAkanksha Sharma, Shiri Keret, Bonny Rockette-Wagner, et al.
Rheumatology (Oxford, England)|August 29, 2024
Disease characteristics and medications use in idiopathic inflammatory myopathy: a multi-centre prospective observational study of decentralized remote vs. traditional clinic enrolmentShiri Keret, Raisa Lomanto Silva, Tanya Chandra, et al.
Clinical and Experimental Rheumatology|December 2, 2025
Health-related quality of life improvements and response thresholds of myositis outcome measures and response criteriaMaha Almackenzie, Anushka Aggarwal, Shiri Keret, et al.
Rheumatology International|August 30, 2024
Heterogeneity in nomenclature and abbreviation usage for anti-synthetase syndrome: a scoping reviewAnushka Aggarwal, Tanya Chandra, Parth Ladha, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Emerging Drugs|June 30, 2020
Clinical trials and novel therapeutics in dermatomyositisTanya Chandra, Rohit Aggarwal
Rheumatology and Therapy|March 26, 2023
A Narrative Review of Acthar Gel for the Treatment of MyositisTanya Chandra, Rohit Aggarwal
Cureus|November 9, 2019
Adalimumab-induced Anti-neutrophilic Cytoplasmic Antibody Vasculitis: A Rare Complication of an Increasingly Common TreatmentTanya Chandra, Joy-Ann Tabanor-Gayle, Santhanam Lakshminarayanan
Indian Journal of Pediatrics|December 22, 2016
Complexities in Genotype-Phenotype Correlation and Genetic Counseling in Collagen VI - Related MyopathyMalavika Hebbar, Tanya Chandra, Anju Shukla, et al.
Rheumatology (Oxford, England)|February 6, 2024
Patient-reported outcome for physical function in idiopathic inflammatory myopathyShiri Keret, Raisa Lomanto Silva, Tanya Chandra, et al.
Clinical Rheumatology|August 26, 2024
Internet-based enrollment of a myositis patient cohort-a national experienceRaisa Lomanto Silva, Shiri Keret, Tanya Chandra, et al.
Clinical and Experimental Rheumatology|February 25, 2026
Fitbit as an activity monitor in idiopathic inflammatory myopathy: results from a real-world cohortAkanksha Sharma, Shiri Keret, Bonny Rockette-Wagner, et al.
Rheumatology (Oxford, England)|August 29, 2024
Disease characteristics and medications use in idiopathic inflammatory myopathy: a multi-centre prospective observational study of decentralized remote vs. traditional clinic enrolmentShiri Keret, Raisa Lomanto Silva, Tanya Chandra, et al.
Clinical and Experimental Rheumatology|December 2, 2025
Health-related quality of life improvements and response thresholds of myositis outcome measures and response criteriaMaha Almackenzie, Anushka Aggarwal, Shiri Keret, et al.
Rheumatology International|August 30, 2024
Heterogeneity in nomenclature and abbreviation usage for anti-synthetase syndrome: a scoping reviewAnushka Aggarwal, Tanya Chandra, Parth Ladha, et al.
Pageof 2